SEC Filings
Madrigal Posts $55.4 Million Quarterly Profit As Rezdiffra Sales Climb 50% To $431.3 Million
The MASH drugmaker says it reached its first profitable quarter, with Rezdiffra year-to-date sales of $1.1 billion.
SEC Filings
The MASH drugmaker says it reached its first profitable quarter, with Rezdiffra year-to-date sales of $1.1 billion.
SEC Filings
The packaging maker held its 2026 outlook, but adjusted EBITDA margin fell to 13.2% from 17.5% a year earlier.
SEC Filings
The pipeline operator also plans about $7 billion in growth spending for 2027, and Sunoco LP's profit more than doubled.
SEC Filings
The LNG exporter priced the notes at 99.313% of par and says proceeds may help refinance a subsidiary's 5.125% notes due 2027.
SEC Filings
The rare-disease drugmaker's board approved the repurchase program days after it raised its 2026 revenue guidance.
SEC Filings
Innolight has also taped out multiple NPO products on Tower's 300mm silicon photonics platform, the two companies said Tuesday.
SEC Filings
The healthcare investment firm, which manages €15 billion, now owns the unit, and a new chief commercial officer has been named.
SEC Filings
The gene-editing company says cash plus a $200 million credit draw lasts into mid-2029, with cash at $1.0 billion.
SEC Filings
Consolidating the Dutch venture lifted reported results, while adjusted EBITDA fell 13.7% on a rebased basis.
SEC Filings
Upstart's cash fell to $461.5 million as a warehouse line turned uncommitted and its loan-performance disclosure changed.
SEC Filings
The browser maker also said its desktop users hit 100 million in October, and it will report full results on November 17.
SEC Filings
The awards pay nothing below the 40th percentile of relative shareholder return and top out at 250% of target.